๐ŸŽ Black Friday: 50% off Unlimited and 30% off Pro annual plans
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM ยท Real-Time Price ยท USD
2.230
-0.120 (-5.11%)
Nov 20, 2026, 4:00 PM EST - Market closed

Sunshine Biopharma Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
35.3736.3134.8724.094.350.23
Revenue Growth
-5.23%4.11%44.75%454.42%1802.41%219.88%
Gross Profit
10.7412.2610.678.341.70.11
Operating Income
-5.96-4.48-5.81-4.79-8.67-2.44
Net Income
-6.17-5.98-5.13-4.51-26.74-12.44
Earnings Per Share
-51.23-287.48----
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
15.049.129.6916.2921.832.05
Total Debt
0.630.810.950.660.771.9
Net Cash (Debt)
14.418.318.7315.6321.060.15
Net Cash Growth
70.55%-4.84%-44.14%-25.77%13687.37%-
Net Cash Per Share
119.63399.85----

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.01-5.33-12.52-8.78-5.25-1.83
Capital Expenditures
0-0.17-1.66-0.08-0.19-
Free Cash Flow
-6.01-5.51-14.18-8.86-5.44-1.83
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
30.36%33.76%30.59%34.61%39.04%48.42%
Operating Margin
-16.84%-12.34%-16.67%-19.86%-199.61%-1068.24%
Pretax Margin
-16.48%-16.40%-15.40%-17.06%-610.07%-5444.41%
Profit Margin
-17.45%-16.46%-14.72%-18.70%-615.44%-5444.41%
FCF Margin
-16.98%-15.16%-40.67%-36.76%-125.24%-800.75%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-38.250.26---
PS Ratio
0.050.170.170.293.30122.82